Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies

Background The EQ-5D is a preference based instrument which provides a description of a respondent's health status, and an empirically derived value for that health state often from a representative sample of the general population. It is commonly used to derive Quality Adjusted Life Year calculations (QALY) in economic evaluations. However, values for health states have been found to differ between countries. The objective of this study was to develop a set of values for the EQ-5D health states for use in Canada. Methods Values for 48 different EQ-5D health states were elicited using the Time Trade Off (TTO) via a web survey in English. A random effect model was fitted to the data to estimate values for all 243 health states of the EQ-5D. Various model specifications were explored. Comparisons with EQ-5D values from the UK and US were made. Sensitivity analysis explored different transformations of values worse than dead, and exclusion criteria of subjects. Results The final model was estimated from the values of 1145 subjects with socio-demographics broadly representative of Canadian general population with the exception of Quebec. This yielded a good fit with observed TTO values, with an overall R2 of 0.403 and a mean absolute error of 0.044. Conclusion A preference-weight algorithm for Canadian studies that include the EQ-5D is developed. The primary limitations regarded the representativeness of the final sample, given the language used (English only), the method of recruitment, and the difficulty in the task. Insights into potential issues for conducting valuation studies in countries as large and diverse as Canada are gained.

[1]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[2]  A. Pickard,et al.  Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada. , 2000, Medical care.

[3]  S. Klarenbach,et al.  Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin , 2010, Canadian Medical Association Journal.

[4]  Paul Kind,et al.  How do Zimbabweans value health states? , 2003, Population Health Metrics.

[5]  A. Williams EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[6]  A. Kasuya EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[7]  G. Bennett,et al.  Smoked cannabis for chronic neuropathic pain: a randomized controlled trial , 2010, Canadian Medical Association Journal.

[8]  George W. Torrance,et al.  Multi-Attribute Health Status Classification Systems , 1995, PharmacoEconomics.

[9]  B. Manns,et al.  Economic evaluation of sirolimus-eluting stents , 2005, Canadian Medical Association Journal.

[10]  M. Mcmurdo,et al.  Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial , 2007, Canadian Medical Association Journal.

[11]  Aki Tsuchiya,et al.  A uniform time trade off method for states better and worse than dead: feasibility study of the 'lead time' approach. , 2011, Health economics.

[12]  Nan Luo,et al.  Valuations of EQ-5D Health States: Are the United States and United Kingdom Different? , 2005, Medical care.

[13]  Mark Oppe,et al.  EQ-5D value sets : inventory, comparative review, and user guide , 2007 .

[14]  K. Schmader,et al.  The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study , 2010, Canadian Medical Association Journal.

[15]  M. Weinstein,et al.  QALYs: the basics. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[16]  Mark Oppe,et al.  Discrete choice modeling for the quantification of health states: the case of the EQ-5D. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  C. Gudex,et al.  Generation of a Danish TTO value set for EQ-5D health states , 2009, Scandinavian journal of public health.

[18]  C. Mcintosh,et al.  Eliciting Canadian population preferences for health states using the Classification and Measurement System of Functional Health (CLAMES). , 2007, Chronic diseases in Canada.

[19]  J. Brazier,et al.  Using a discrete choice experiment to estimate health state utility values. , 2012, Journal of health economics.

[20]  R. Brooks EuroQol: the current state of play. , 1996, Health policy.

[21]  Stephen Joel Coons,et al.  US Valuation of the EQ-5D Health States: Development and Testing of the D1 Valuation Model , 2005, Medical care.

[22]  Richard Norman,et al.  Does mode of administration matter? Comparison of online and face-to-face administration of a time trade-off task , 2010, Quality of Life Research.

[23]  Joshua A Salomon,et al.  Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data , 2003, Population health metrics.

[24]  W. Brouwer,et al.  Lead time TTO: leading to better health state valuations? , 2013, Health economics.

[25]  C. Carswell Measuring and Valuing Health Benefits for Economic Valuation , 2007, PharmacoEconomics.

[26]  G W Torrance,et al.  A utility maximization model for evaluation of health care programs. , 1972, Health services research.

[27]  C. Gudex,et al.  Time trade-off user manual: props and self-completion methods , 1994 .

[28]  Nandini Dendukuri,et al.  Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis , 2007, Canadian Medical Association Journal.

[29]  G W Torrance,et al.  Multi-attribute health status classification systems. Health Utilities Index. , 1995, PharmacoEconomics.

[30]  L. Lamers The Transformation of Utilities for Health States Worse Than Death: Consequences for the Estimation of EQ-5D Value Sets , 2007, Medical care.

[31]  Willingness of patients to change surgeons for a shorter waiting time for joint arthroplasty , 2008, Canadian Medical Association Journal.

[32]  M. Weinstein,et al.  Preference-based measures in economic evaluation in health care. , 2000, Annual review of public health.

[33]  Paul Kind,et al.  Logical inconsistencies in survey respondents' health state valuations -- a methodological challenge for estimating social tariffs. , 2003, Health economics.

[34]  Dan Greenberg,et al.  Trends in the measurement of health utilities in published cost-utility analyses. , 2006, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[35]  N. Ikegami,et al.  Estimating an EQ-5D population value set: the case of Japan. , 2002, Health economics.

[36]  L. Lynd,et al.  Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy , 2006, Canadian Medical Association Journal.

[37]  Esther Seiden,et al.  On Orthogonal Arrays , 1966 .

[38]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[39]  C. Cameron,et al.  Cost-effectiveness of insulin analogues for diabetes mellitus , 2009, Canadian Medical Association Journal.

[40]  P. Stalmeier,et al.  The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. , 2006, Health economics.